µÚËľüÒ½´óѧһ¾Å¾Å¶þÄê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧÊÔÌâ ѧ¿Æ×¨Òµ£º y7iHB
k"^:
$ mH'%YDIl
´«È¾²¡Ñ§ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ qFqK.u
l,}^<P]
Ò». Ãû´Ê½âÊÍ(ÿÌâ4·Ö,¹²32·Ö) VLLE0W _]
\=3fO(
1. ICAM-1 J5i$D0K[
S"}G/lBx.
2. interleukin 12(IL-12) =Gl6~lJ{_
**RW
9FU
3. tumor infiltrating lymphocyte ,WvCslZ
Cob<N
'.
4. TCR/CD3 complex h'QEwW
p3e_:5k
5. hematopoietin receptor family c8R#=^ DD
!)!<.x
6. individual idiotype(IdI) [ X7LV
Cp`>dtCd
7. integrin I;=HXL
Zze(Ik
8. colony-stimulatory factor (CSF) $qvk9 B0E
:o2^?k8k
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© |FR'?y1
t;^NgkP{$
1. ÃâÒßÇòµ°°×ÖØÁ´µÄ»ùÒòÈçºÎ½øÐÐÀà±ðת»»(class switching )? -5&|"YYjr{
z?b[ 6DLV;
2. ¼òÊöɱÉËÐÔTϸ°û(Tc)ɱÉ˲¡¶¾¸ÐȾ°Ðϸ°ûµÄ»úÀí¡£ J2vaKl
31FQ=(K
3. ÉúÎïÓ¦´ðµ÷½Ú¼Á( biological response modifier,BRM)Ö÷ÒªÓÐÄļ¸Àà?¼òÒª½éÉÜÔÚ´«È¾ÐÔ¼²²¡·ÀÖÎÖеÄ×÷Óᣠc:$W5j('Z
8J5{}4s\f
4. ¼òÊö¿¹ÔÌá³Êϸ°û(APC)Ó븨ÖúÐÔTϸ°û(Th)Ï໥×÷ÓõĹØÏµ¡£ +WxZB
\W;+@w|c
Èý. ÎÊ´ðÌâ(ÿÌâ18·Ö,¹²36·Ö) =m+'orJ1
/q3]AVV
1. ÊÔÊö¸ÉÈÅËØµÄ·ÖÀ༰ÆäÉúÎïѧ×÷ÓÃÌØµã¡£Ö÷Òª¿ÉÒÔÖÎÁÆÄÄЩ´«È¾ÐÔ¼²²¡?¼òÊö¸ÉÈÅËØ¼ì²âµÄ·½·¨ºÍÔÀí¡£ #]vy`rv
)q+Qtz6D
2. ºÎΪ»ùÒò¹¤³Ì¿¹Ìå?Ŀǰ¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? µÚËľüÒ½´óѧһ¾Å¾ÅÈýÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: ´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 1. CD4 2. T cell receptor(TCR) cb9ndZ)v.
L_k'r\L
3. immunoglobulin superfamily (IgSF) O<:"Irq\qr
GD]yP..
4. selectin !8z,}HUdK
BB>R=kt
5. anti-idiotypic antibody (¦ÁId) 0U
d.u
RCgn\
6. major histocompatibility complex(MHC) ~boTh
Ki8]+W37
7. immunotolerance 5Az4 <
U|NVDuo{{x
8. biological reponse modifier(BRM) IpRdGT02
~S$\ PG4
9. immune reponse gene (Ir gene) FA+'E
}H>
}v/
10. reshaped antibody (or reconstituted antibody) -=+@/@nV
<z=d5g{n
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© oaK&!$S]
K).Gj2 $
1. ¼òÊö°×ϸ°û½éËØ6(IL-6)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¡£ yLDv/r
:'F7^
N3;H
2. ϸ°û¶¾ÐÔTÁܰÍϸ°û(Tc»òCTL)Ó뿹ÌåÒÀÀµµÄϸ°û½éµ¼µÄϸ°û¶¾(ADCC)ɱÉË»úÀíÓкβ»Í¬? -q8R'?z[
gaIN]9wLm
3. ¼òÊöµÚ¢ôÐÍ(³Ù·¢ÐÍ)±ä̬·´Ó¦µÄ·¢Éú»úÀí¡£ kt0ma/QpP
H/v|H}d;
4. NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄ±íÃæ±ê¼Ç?NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄÉúÎïѧ»îÐÔ? "s6\l~+9l
I|SQhbi
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö) ¹©´«È¾²¡Ñ§×¨ÒµÊÔÌ⣺ .}O _5b(
5g-AB`6T
1. »úÌåÓÐÄÄЩÃâÒßϸ°ûºÍÃâÒß·Ö×Ó²ÎÓ뿹²¡¶¾¸ÐȾ?ËüÃÇÊÇÈçºÎ·¢»Ó²¡¶¾ÃâÒß×÷ÓõÄ? WqHsf1?N
mHY R?
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚ²¡¶¾Ñ§ÖÐÓÐÄÄЩÖ÷ÒªÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ ):c)$$dn
e[:i`J
2
¹©Ïû»¯ÄÚ¿Æ×¨ÒµÊÔÌ⣺ k v>rv37u
SdJGhU
1. ĿǰÌåÄÚºÍÌåÍâ¼ì²âÖ×Áö»¼ÕßÃâÒß¹¦Äܵķ½·¨Ö÷ÒªÓÐÄÄЩ?·Ö±ðÐðÊöÿÖÖ·½·¨µÄÔÀíºÍ½á¹û²â¶¨? DMc H, _(
JJ+A+sfdk
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚÖ×ÁöѧÖÐÓÐÄÄЩÖ÷ÒªµÄÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ 7SyysH<H
/ta5d;@
µÚËľüÒ½´óѧһ¾Å¾ÅËÄÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: GlPd)m`
`/4R$E{
´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: :Nt_LsH
L6ifT`;T
̉񧄤 e0nr dM[i
dP7nR1GS
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© @N% /v*
b;O@|HK&~
1. CD8 B'kV.3t
=rB=! ;
2. T cell receptor ¦Á and ¦Â chain (TCR¦Á¦Â ) W7
.Y`u[
wyVQV8+&>
3. immunoglobulin fold(Ig fold) 0Gr ^#`
?cH,!2
4. cadherin (Ca-dependent cell adhesion moleculers) mx ]a@tu
i"HENJyCb
5. idiotype-anti-idiotypic antibody immune network theory 5J1q
]^
- UMPt"o
6. HLA class II antigen @8jc|X<A
D#pZN,'
7. complementarity-determining region (CDR) 2GB+st,
ee7{5
8. perforin(or pore-forming protein ,PFP) B4>kx#LR
KXtc4wra
9. high affinity IL-2 receptor )=:gO`"D
_Cd_i[K[
10. artificial active immunization ,]\: ]Y&?
&M5_G$5n
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© i]L4kh5
|fd}B5!c
1. ¼òÊö°×ϸ°û½éËØ2(IL-2)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¼°ÆäÔÚÁÙ´²ÖÎÁÆÖеÄÓ¦Óᣠxwm-)~L4T
L
2Z9g`>
2. Çë±È½ÏµÚ¢ñÐÍ(ËÙ·¢ÐÍ)³¬Ãô·´Ó¦ÓëµÚ¢ôÐÍ(³Ù·¢ÐÍ)³¬Ãô·´Ó¦µÄ·¢²¡Ìص㡣 +~H mPQ
Z#i5=,Bk
3. ÊÔÊö·ÖÃÚÐÍIgA(secretory IgA)µÄ½á¹¹ÌصãºÍºÏ³É·ÖÃÚ¹ý³Ì¡£ dl
%KD8
kV mJG#
4. ÊԱȽÏT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(Èç±íÃæ¿¹Ô¡¢±íÃæÊÜÌåµÈ)µÄÒìͬµã¡£ ] SErM#$*
potb6jc?
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö¡£Çë×¢Ò⣺ÿλ¿¼ÉúÖ»ÄÜ´Ó1¡¢2ÌâÖÐѡһÌâ,3¡¢4ÌâÖÐѡһÌâ,¹²´ðÁ½Ìâ,¶à´ðÕß²»¼Æ·Ö¡£) 1. Ŀǰ¼ì²âϸ°ûÒò×ÓÖ÷ÒªÓÐÉúÎïѧ»îÐÔ¼ì²â·¨ºÍÃâÒßѧ¼ì²â·¨,Çë¾ÙÀý·Ö±ðÐðÊöÁ½ÖÖ·½·¨µÄʵÑéÔÀí¡£ ;44?`[oP
b
O:m^*
2. ΪÁ˱ÜÃâIgG¿¹ÌåFc¶Î·ÇÌØÒìÐÔ×÷ÓÃ,³£Ó¦ÓÃθµ°°×øˮ½âµÄF(ab¡¯)2¶Î,ÊÔÎÊÈçºÎÓ¦ÓÃSDS-PAGE·½·¨¶ÔF(ab¡¯)2½øÐмø¶¨? ti)4J2c,8
%L^S;v3
3. ÊÔÊö¿¹Ö×Áö»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ o (OC3
7T)J{:+0!|
4. ÊÔÊö¿¹²¡¶¾»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ ¡¡ .-0;:>
-c1$>+
µÚËľüÒ½´óѧһ¾Å¾ÅÎåÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ DJF-J#
'za4c4b*u
ѧ¿Æ×¨Òµ£ºÃâÒßѧ¡¢´«È¾²¡Ñ§¡¢Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ 'aWzam>
A^a9,T
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© W9$mgs=S`E
m9Z 3q ;
1. immunoglobulin gene rearrangement TAbC-T.EV
rdL>yT/A
2. the common chain of cytokine receptor (or a cytokine receptor subunit shared by some cytokine receptors) Dyx3N5?C
u/D=&"tL
3. flow cytometry(FCM) f"0{e9
O]2
#\&jM
-.-
4. carrier effect ={a8=E!;
9tnW:Nw~
5. positive selection of T lymphocytes in thymus Y^? J3[@
@jE<V=?
6. mouse TH1(Th1) and TH2(Th2) subsets R ks3L
]0HlPP:2
7. perforin (pore-forming protein ,PFP) [-@Lbu-|
$=j}JX}z
8. ADCC(antibody-dependent cell-mediated cytotoxicity) Hm?zMyO.k
T/^ /U6JB
9. SH-2(src-homology region 2) &&
}'
T[iwP~l
10. Ab2¦Â (internal image) ;b[% L&
(~r"N?`
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© uC>X;<^
Ksq{=q-T
1. ½üÄêÀ´ÔÚÈËÀà°×ϸ°û·Ö»¯¿¹Ô(CD)Ñо¿ÁìÓòÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? Z[baQO
NU*6MT4
2. ²ÎÓë»î»¯Tϸ°ûÓë»î»¯Bϸ°ûÏ໥×÷ÓõķÖ×ÓÖ÷ÒªÓÐÄÄЩ?¼òÊöÆä½á¹¹ºÍ¹¦ÄÜ? 0
R,?$qM\
+h6cAqm]
3. ÊÔÊöHLAÔÚÁÙ´²ÉϵÄÖ÷ÒªÓ¦Óᣠi;
1aobG
Q0f7gY1-%
4. Àý¾ÙÈýÖÖ´ÓÈËÍâÖÜѪµ¥¸öºËϸ°û(PBMC)Öд¿»¯Tϸ°ûµÄ·½·¨,·Ö±ðÐðÊöÆäʵÑéÔÀíºÍÖ÷Òª²Ù×÷²½Öè¡£ -E4e8'P;5
@)>9l&
5. ÆÀ¼Ûºìϸ°ûÉú³ÉËØ(EPO)¡¢¸ÉÈÅËØ(IFN)ºÍ¼¯Âä´Ì¼¤Òò×Ó(CSF)ÔÚÁÙ´²Ä³Ð©¼²²¡µÄÓ¦ÓᣠqV$\.T>x
-.|V S|y
Èý. Ñ¡ÔñÎÊ´ðÌâ(ÿÌâ10·Ö,¹²20·Ö¡£Çë°´±¨¿¼×¨Òµ´ðÌâ,Èç´ð·Ç±¾×¨ÒµÌâ»ò¶à´ðÌâ¾ùÊÓΪÎÞЧ¡£) _5vAnt*
[N}:Di,S
ÃâÒßѧרҵ£º [YY[E 7
SU.T0>w
1. ÊÔÊöϸ°ûÒò×ÓÊÜÌåÖÐ,Ig³¬¼Ò×å¡¢ÔìѪÒò×ÓÊÜÌ峬¼Ò×å¡¢Éñ¾Éú³¤Òò×ÓÊÜÌ峬¼Ò×åÒÔ¼°Ç÷»¯Òò×ÓÊÜÌ峬¼Ò×åµÄÖ÷Òª½á¹¹Ìصã,ÿ¸ö³¬¼Ò×åÀý¾Ù³ö2¸ö³ÉÔ±¡£ %aU4d
e^
x8Rmap@L.
2. ÊԱȽÏÈËT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(±íÃæ±ê¼Ç)µÄÒìͬµã,ËüÃÇ·Ö±ð²ÎÓëÄÄЩÖ÷ÒªµÄÃâÒß¹¦ÄÜ? 1!"0fZh9U
K@P5]}'#
´«È¾²¡Ñ§×¨Òµ£º [kx_Izi/T
gaaW:* *y
1. ÈËÀàÃâÒßȱÏݲ¡¶¾(HIV)¸ÐȾÈËÌåºó,ÃâÒß¹¦Äܿɷ¢ÉúÄÄЩÖ÷ÒªµÄ±ä»¯?»úÀíÊÇʲô?ÈçºÎ½øÐÐÏàÓ¦µÄÃâÒßѧ¹¦Äܼì²â£¿ ZPWY0&9
LlP_`fA
2. ÇëÆÀÊöÉö×ÛºÏÕ÷³öѪÈȲ¡¶¾(HFRSV)¸ÐȾºó»úÌåÃâÒßѧ±ä»¯µÄÓ벡ÀíËðÉ˵ĹØÏµ¡£ ,[}5@cS
%EYh5W
Ïû»¯×¨Òµ£º " d3pkY
SF2A?L?}+
1.ÊÔÊöÓëÏû»¯ÏµÍ³ÓйصÄÖ×ÁöÏà¹Ø¿¹ÔÑо¿µÄ½øÕ¹¡£ $9dm2#0d
$\l7aA5~
2.¼òÊöճĤÏà¹ØÁܰÍÑù×éÖ¯(mucosal assiociated lymphoid tissue,MALT)µÄ×é³ÉºÍ¹¦ÄÜÌØµã¡£·ÖÃÚÐÍIgAÊÇÈçºÎ½øÐкϳɺͷÖÃÚµÄ? 6LRI~*F=3
;aKdRhDo
µÚËľüÒ½´óѧһ¾Å¾ÅÁùÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ÃâÒßѧÊÔÌâ h
V@C|*A
{dV#"+
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© ?y82S*sb#
3!M;Z7qF]
1. Fas(CD95)/FasL E(A7D XzbR
<>`+"O}
2. common chain of cytokine receptor 2Q`@lTUv
Bi9
b"*LN
3 . TCR/CD3 complex W8j)2nKD
Hzs]\%"
4. negaive selection of thymocytes
*r Y6
^~Nz8PCY
5. artificial active immune deSrs:.
bj4cW\b(
6. anti-idiotypic 8FyJo.vr(
VyH'7_aU
7. IgSF ^OKCvdS
xg %EQ
8. Integrin `2\vDy1,j
zRPX
mu{t
9. chemokine <@xp. Y
v;"[1w}
10. B7/CD28 I=X-e#HM?
n5dFp%k
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£©
$wUFHEl
Q{6Bhx *>
1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£
:RR<-N5+
'F3Xb
2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£ }N^.4HOS8
_2+}_ >d
3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ $A\fm`
$6.CN#
4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£ @ qWgokf
pMM,ox"
5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£ $}&Y$w>S
L
A-H
µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ 9 lE[oAC
(&R/ns~
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© g*69TqO^
B}_*0D
1. B7/CD28 yi*)g0M
O@r%G0Jge
2. Th1 subset >aXyi3B
c}GmS@
3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£© heJ I5t,
$,$bZV
4. antibody affinity maturation 7YT%.ID
-
y[nMEE
5. AP-1 -Yx'qz@
6Mu_9UAl`
6. single chain variable fragment£¨ScFv£© DX
u915
vw VeHjR
7. NK cell receptor 1y@d`k`t:
("-Co,4ey
8. Zinkernagel-Doherty phenomenon A\p'
\@f
)
=-$>75Z
9. Ig fold $SAq/VHI1]
_b8&$\>
10. CD40/CD40L ZDEz&{3U;
J%ng8v5ex
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£© ap
hfzo
j"6r]nc&
1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£ l~P%mVC3m
3cfJ(%'X
2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿ ~ 8L]!OQ9=
k4:$LFw@
3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿ `-@8IZ7
+KV?W+g)`
Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩ }e$^v*16
}j<:hDQP
1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£ '}#=I 9=ss
8@;|x2=y
2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£ B(tLV9B3Q
%oPW`r
3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£ 0u[Vd:()v(
<Y%km[Mh
Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ £¨ÃâÒßѧרҵºÍרҵ»ù´¡£© 7{jB!Xj
Fg` P@hC
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© 0
D^d-R,
+xoh=m
1.Co-stimulators (or co-stimulating molecules) FuqMT`
a,eR'L<"*-
2.NK-kB x=-dv8N?
scr`] tD
3.Immunoglobulin superfamily %3p~5jhm1
\
a}6NIo
4.antigen-presenting cell (APC) $z1W0
;MSdTHN"
5.death domain \iN3/J4
&Bn>
YFu
6.CCR and CXCR
Ltk'`
v67utISNI
7.Lectin (or mitogen) op!ft/Yyb
C1V
:_-
8.Clusters of differentiation, CD) gc5u@
(P"
I`e$U
9.B7 family VIIBw
<H; z4
10.Cytotoxic T lymphocyte, CTL) i sK_t*
yM_ta '^$
11.IL-15 and IL-15 receptor (IL-15R) U3UKu/Z
30BFwNE
12.MHC restriction jRn5)u
N*^iOm]Y
13.Affinity-chromatography <^+x}KV I
SRP.Mqg9
14.Cyctosprin A, CsA 1\t# *N
1')_^]
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) }q$6^y
6np
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© MbT;]Bo
MBIlt
1P
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 5YV3pFz$)
o[A y2"e?
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ s^&Oh*SP*
{s{b
nU
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ /W|=Or2oR
w'r?)WW$
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© 1H-d<G0)
;h"St0
ÃâÒßѧרҵ£º )%zOq:{\5
u4KP;_,m
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ TXWYQ~]3w
/0_^Z2
Ïû»¯ÄÚ¿Æ£º 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ 5R%4fzr&g
wCitQ0?
ѪҺ²¡Ñ§×¨Òµ£º 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿ \*+-Bm:$j
'JpCS
Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ (רҵ»ù´¡: ÃâÒßѧ) 0XzrzT"&
uD0<|At/
Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö) }\?]uNH
~Qm<w3oy
1. ADCC(antibody dependent cell-mediated cytotoxicity) dRGgiQO
$&ZN%o3
2. »·æß¾úËØ(cyclosporin) n#
4e1n+I
6>d0i
S@R
3. KIR(killer cell inhibitory receptor) S2\|bs7;J,
*RllKP Y)
4. HLDA(human leucocyte differentiation antigen) KmX?W/%R
XIRvIwO
5. Interleukin 18(IL-18) JW2~
G!@
!?aL_{7J
6. ÕûºÏËØ(integrin) wgcKeTD9
@\?QZX(H
7. Fas/FasL qZB}}pM#
*t_JR
8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå) =C4!h'hz
XdV(=PS!a@
9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM) ^77X?nDz=h
@3Nvf}He
10. Th1/Th2 nJr:U2d
e .(
11. »ùÒòÒßÃç(DNAÒßÃç) "yG*Kh7ur
zcCGREe=
12. chemokines and chemokine receptor }pOJ M&I
RA
ER\9i
13. ÃâÒßÄÍÊÜ 3aERfIJyE
lEr_4!h$rZ
14. ¹²´Ì¼¤·Ö×Ó )9~-^V0A^>
"]kq,j^]
15. ËÀÍö½á¹¹Óò(death domain) Cp!Qd e
`CqF&b
¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö) $
(N+E,XB
~7O.}RP0
1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬? )^[PW&=W|x
~(Xzm
2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óᣠhw)#TEt
-XMWN$Ah
£¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î /
PTk296@
XFJz\'{
£¨2£©1977Ä꣺·ÅÉäÃâÒß·¨ 9 6j*F,{
h:~
8WV|
£¨3£©1984Ä꣺ÁܰÍϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå ]h4r@L3
&!0%"4
£¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹ 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄÐ©ÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£ v i~NfD@s
"S^""5
Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ) ÎÊ´ðÌâ(ÿÌâ25·Ö) Rw]lW;EN<
`71(wf1q[f
1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£ iVAAGZ>am
(GB*+@
2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿ \
ix&U
gf^XqTLs
3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆÒ»ÏµÍ³ÊµÑé,¼ÓÒÔ֤ʵ¡£ 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃǰ¾°¡£